| Revenue growth | Q2 +3.3%; ex-Pril/Fa value +12.4% |
|---|---|
| Margins | Gross margin 34.8% vs 48.1%; EBITDA 2.5% vs 16.1%. |
| Demand visibility | Demand resilient; rural healthy, urban gradually improving. |
Growth
Q2 revenue +3.3% to ₹760 Cr; ex-Pril & Fa value +12.4%, volume +8.1%. PAT -87.9% to ₹10.6 Cr.
Outlook
No numeric growth guidance. Plans selective price increases, calibrated pricing, procurement and value engineering; progressive margin improvement targeted.
Risks
Gross margin fell to 34.8% (from 48.1%) on abnormal raw-material and packaging inflation; commodity pressure remains elevated.
Investor Presentation filed with BSE, NSE: JYOTHYLAB. Summary written with AI assistance from the document.
Jyothy Labs Ltd: key numbers
- Share price
- ₹183.00
- Market cap
- ₹6,720 Cr
- Revenue (annual)
- ₹2,944 Cr
- Net profit (annual)
- ₹333.2 Cr
- P/E (TTM)
- 23.7×Sector 40.4×
- Promoter holding
- 62.89%+0.00% QoQ
- FII holding
- 14.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jyothy Labs Ltd
All →Jyothy Labs Results Update
Jyothy Labs posted Q2 FY27 revenue of ₹760 crore and PAT of ₹10.6 crore. H1 FY27 revenue reached ₹1,533 crore with PAT of ₹58.2 crore amid margin pressure.
Jyothy Labs Q2 FY27 Results: Net Profit ₹10.6 Cr, Down 87.9% YoY
Jyothy Labs Ltd reported revenue from operations of ₹760 Cr (+3.2% YoY) and net profit of ₹10.6 Cr (-87.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10.6 Cr · -87.9% YoY
Jyothy Labs Board Meeting Date
Jyothy Labs intimated that its board meets on November 4, 2026 to consider a proposal for buyback of fully paid-up equity shares. Trading window stays closed until 48 hours after the outcome is disclosed.
Jyothy Labs Promoter Buying (Off-Market)
Jyothy Labs filed its quarterly shareholding pattern. It disclosed an inter-se gift of shares within the promoter group, adding family trusts to the promoter group category.
Jyothy Labs Board Meeting Date
Jyothy Labs has scheduled its Board of Directors meeting for November 4, 2026. The agenda includes approval of un-audited financial results for Q1 and H1 2026.
Jyothy Labs Employee Stock Options
Jyothy Labs allotted 21,009 equity shares upon exercise of Restricted Stock Units. This increases the company's total paid-up share capital.